Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma.
Saved in:
| Title: | Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma. |
|---|---|
| Authors: | Wang J; Department of Pharmacology, University of Michigan, Ann Arbor, MI, 48109, USA., Al-Majid D; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, MSRB III 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA., Brenner JC; Department of Pharmacology, University of Michigan, Ann Arbor, MI, 48109, USA. chadbren@med.umich.edu.; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, MSRB III 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA. chadbren@med.umich.edu.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA. chadbren@med.umich.edu., Smith JD; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, MSRB III 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA. |
| Source: | Targeted oncology [Target Oncol] 2023 Sep; Vol. 18 (5), pp. 643-655. Date of Electronic Publication: 2023 Sep 04. |
| Publication Type: | Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1776-260X |
|---|---|
| DOI: | 10.1007/s11523-023-00993-3 |
